Akiva Diamond

Assistant Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Akiva Diamond is an Assistant Professor at Baylor College of Medicine in the United States. His research primarily focuses on oncology, particularly the clinical outcomes and treatment strategies for older patients with various types of cancer, including lymphoma and chronic lymphocytic leukemia. Recent publications have addressed the safety and efficacy of targeted therapies and the management of treatment-related cardiovascular risks in elderly populations.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Asrar Alahmadi

Assistant Professor

Ohio State University

UNITED STATES

View details

Fei Ye

Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Mouhamed Yazan Abou-Ismail

University of Utah

UNITED STATES

View details

Teja Ganta

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Rock Bum Kim

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Akiva Diamond

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Inhibiting JAK1: lowering CRS, CAR stays on track

Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study

Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system

From mutation to management: Advancing Langerhans cell histiocytosis treatment through combination therapies

Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients

Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors among Patients Aged 80 Years or Older with Cancer: A Multicenter International Cohort Study

Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

Collaborators (5)

Asrar Alahmadi

Fei Ye

Mouhamed Yazan Abou-Ismail

Teja Ganta

Rock Bum Kim

Make your next move.